BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/6/2018 1:33:44 AM | Browse: 985 | Download: 1343
 |
Received |
|
2018-05-27 05:27 |
|
Peer-Review Started |
|
2018-05-27 09:57 |
|
To Make the First Decision |
|
2018-07-04 01:26 |
|
Return for Revision |
|
2018-07-06 06:57 |
|
Revised |
|
2018-07-09 07:25 |
|
Second Decision |
|
2018-07-13 08:38 |
 |
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2018-07-16 01:38 |
|
Articles in Press |
|
2018-07-16 01:38 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2018-08-31 09:13 |
|
Publish the Manuscript Online |
|
2018-09-06 01:33 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Minireviews |
| Article Title |
Antiangiogenic therapy for portal hypertension in liver cirrhosis: Current progress and perspectives
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Dmitry Victorovich Garbuzenko, Nikolay Olegovich Arefyev and Evgeniy Leonidovich Kazachkov |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| RFBR |
18-315-00434 |
|
| Corresponding Author |
Dmitry Victorovich Garbuzenko, MD, PhD, Professor, Department of Faculty Surgery, South Ural State Medical University, Box 12317, Chelyabinsk 454080, Russia. garb@inbox.ru |
| Key Words |
Liver cirrhosis; Portal hypertension; Pathogenesis; Angiogenesis; Antiangiogenic therapy |
| Core Tip |
This review describes the role of angiogenesis in the pathogenesis of portal hypertension in liver cirrhosis and the prospects of antiangiogenic therapy. The analysis of the data showed that angiogenesis plays an important role in the pathogenesis of cirrhosis and accompanies portal hypertension, underlying its development and causing related complications. Although most of angiogenesis inhibitors were studied only in animal experiments, this selective therapy for abnormally growing newly formed vessels is pathogenetically reasonable to treat portal hypertension and associated complications. |
| Publish Date |
2018-09-06 01:33 |
| Citation |
Garbuzenko DV, Arefyev NO, Kazachkov EL. Antiangiogenic therapy for portal hypertension in liver cirrhosis: Current progress and perspectives. World J Gastroenterol 2018; 24(33): 3738-3748 |
| URL |
http://www.wjgnet.com/1007-9327/full/v24/i33/3738.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v24.i33.3738 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
